End Cash (Annual)

End Cash: The amount of cash held by the company for the given period.

BioLineRx Ltd. (BLRX) had End Cash of $3.25M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$1.18M
Net Income	$-1.18M
Cost of Goods Sold	$0.23M
Gross Profit	$0.95M
Operating Expenses	$11.47M
Operating Income	$-10.29M
Non-Operating Income/Expense	$8.26M
Pre-Tax Income	$-2.03M
Normalized Pre-Tax Income	$-2.03M
Income after Taxes	$-2.03M
Income from Continuous Operations	$-2.03M
Consolidated Net Income/Loss	$-2.03M
Normalized Income after Taxes	$-2.03M
EBIT	$-10.29M
EBITDA	$-9.76M
Weighted-Average Shares Outstanding (Basic)	4.11M
Weighted-Average Shares Outstanding (Diluted)	4.11M
Earnings per Share (EPS) (Basic)	$0.00
Earnings per Share (EPS) (Diluted)	$0.00
Balance Sheet Financials
Current Assets	$23.68M
Property, Plant, and Equipment	$0.16M
Long-Term Assets	$17.22M
Total Assets	$40.91M
Current Liabilities	$12.12M
Long-Term Debt	$4.46M
Long-Term Liabilities	$5.44M
Total Liabilities	$17.56M
Common Equity	$23.34M
Tangible Shareholders Equity	$6.98M
Shareholders Equity	$23.34M
Common Shares Outstanding	2.61M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-8.07M
Cash Flow from Investing Activities	$-8.54M
Cash Flow from Financial Activities	$8.88M
Beginning Cash	$10.44M
End Cash	$3.25M
Increase/Decrease in Cash	$-7.19M
Stock-Based Compensation	$0.40M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.95
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.16
Debt to Equity Ratio	0.38
Gross Margin	80.51%
Operating Margin	-871.78%
EBIT Margin	-871.78%
EBITDA Margin	-827.46%
Pre-Tax Profit Margin	-171.69%
Profit Margin	-99.58%
Free Cash Flow	$-8.10M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.03
Inventory Turnover	0.11
Receiveable Turnover	2.59
Days Sales in Receivables	141.05
Return on Equity	-8.68%
Return on Tangible Equity	-29.04%
Return on Assets	-4.95%
Return on Investments	-7.29%
Book Value Per Share	$8.94
Free Cash Flow per Share	$-1.97
Operating Cash Flow per Share	$-1.97

Data from Zacks Investment Research, Inc.